Next Article in Journal
The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell Disease
Next Article in Special Issue
Initial Evaluation of Prospective and Parallel Assessments of Cystic Fibrosis Newborn Screening Protocols in Eastern Andalusia: IRT/IRT versus IRT/PAP/IRT
Previous Article in Journal / Special Issue
Diagnosis of Carnitine Deficiency in Extremely Preterm Neonates Related to Parenteral Nutrition: Two Step Newborn Screening Approach
Open AccessArticle

Newborn Sickle Cell and Thalassaemia Screening Programme: Automating and Enhancing the System to Evaluate the Screening Programme

NHS Sickle Cell and Thalassaemia Screening Programme, Public Health England, London SE1 8UG, UK
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2019, 5(3), 30; https://doi.org/10.3390/ijns5030030
Received: 25 July 2019 / Revised: 22 August 2019 / Accepted: 27 August 2019 / Published: 31 August 2019
(This article belongs to the Special Issue Selected Papers from 11th ISNS European Regional Meeting)
Good information is needed to demonstrate that a screening programme is meeting its objectives, to measure performance against standards and to ensure that action is taken if standards are not met. In 2010, the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme established a process to collect data on the main outcome measures for newborn babies. In 2016, a review identified that data completeness and quality relied on manual processes and there was widespread dissatisfaction amongst data providers due to duplication of data entry, poor feedback and lack of oversight of the baby to ensure safe handover from screening into treatment services. Using an Agile service design process and following the Government Digital Service Model, the SCT Screening Programme worked in close collaboration with users, wider stakeholders and system suppliers to design and build a new automated system. The new system ensures that the screening programme can fulfil its duty to evaluate the effectiveness of the programme, whilst pleasing the users and enhancing safety. User experience must be central to design and ongoing development to ensure that a new IT system is fit for purpose and adopted by users. View Full-Text
Keywords: sickle cell; thalassaemia; screening; newborn; outcome data; evaluation; Agile project sickle cell; thalassaemia; screening; newborn; outcome data; evaluation; Agile project
Show Figures

Figure 1

MDPI and ACS Style

Coppinger, C.; O’Loughlin, R. Newborn Sickle Cell and Thalassaemia Screening Programme: Automating and Enhancing the System to Evaluate the Screening Programme. Int. J. Neonatal Screen. 2019, 5, 30.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop